XML 23 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
$ in Thousands
Total
Third Party Joint Ventures [Member]
Common Stock [Member]
Class S Shares [Member]
Common Stock [Member]
Class I Shares [Member]
Common Stock [Member]
Class T Shares [Member]
Common Stock [Member]
Class D Shares [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit and Cumulative Distributions [Member]
Total Stockholders' Equity [Member]
Non-controlling Interests [Member]
Third Party Joint Ventures [Member]
Non-controlling Interests [Member]
BREIT OP Unitholders [Member]
Beginning Balance at Dec. 31, 2018 $ 3,914,954   $ 2,770 $ 1,083 $ 233 $ 304 $ 4,327,444 $ (587,548) $ 3,744,286 $ 75,592 $ 95,076
Common stock issued 2,811,230   1,024 1,231 89 221 2,808,665   2,811,230    
Offering costs (153,874)           (153,874)   (153,874)    
Distribution reinvestment 93,894   52 25 4 5 93,808   93,894    
Common stock/units repurchased (105,667)   (34) (55) (7) (1) (105,500)   (105,597)   (70)
Amortization of restricted stock grants/compensation awards 1,200     2     198   200   1,000
Net income (loss) (102,529)             (97,550) (97,550) (3,006) (1,973)
Distributions declared on common stock (160,413)             (160,413) (160,413)    
Contributions from non-controlling interests 87,406                 45,943 41,463
Distributions to non-controlling interests (8,385)                 (4,804) (3,581)
Allocation to redeemable non-controlling interests (1,441)           (1,441)   (1,441)    
Ending Balance at Jun. 30, 2019 6,376,375   3,812 2,286 319 529 6,969,300 (845,511) 6,130,735 113,725 131,915
Beginning Balance at Dec. 31, 2018 3,914,954   2,770 1,083 233 304 4,327,444 (587,548) 3,744,286 75,592 95,076
Ending Balance at Dec. 31, 2019 10,614,648   5,308 4,743 398 847 11,716,721 (1,422,885) 10,305,132 157,795 151,721
Beginning Balance at Mar. 31, 2019 4,591,704   3,190 1,322 267 381 5,115,490 (703,936) 4,416,714 77,173 97,817
Common stock issued 1,967,111   610 986 51 146 1,965,318   1,967,111    
Offering costs (103,027)           (103,027)   (103,027)    
Distribution reinvestment 51,860   28 14 2 3 51,813   51,860    
Common stock/units repurchased (60,157)   (16) (37) (1) (1) (60,032)   (60,087)   (70)
Amortization of restricted stock grants/compensation awards 600     1     99   100   500
Net income (loss) (52,710)             (50,704) (50,704) (970) (1,036)
Distributions declared on common stock (90,871)             (90,871) (90,871)    
Contributions from non-controlling interests 77,798                 41,049 36,749
Distributions to non-controlling interests (5,572)                 (3,527) (2,045)
Allocation to redeemable non-controlling interests (361)           (361)   (361)    
Ending Balance at Jun. 30, 2019 6,376,375   3,812 2,286 319 529 6,969,300 (845,511) 6,130,735 113,725 131,915
Beginning Balance at Dec. 31, 2019 10,614,648   5,308 4,743 398 847 11,716,721 (1,422,885) 10,305,132 157,795 151,721
Common stock issued 5,951,825   1,243 3,713 60 214 5,946,595   5,951,825    
Offering costs (126,380)           (126,380)   (126,380)    
Distribution reinvestment 228,166   99 88 6 15 227,958   228,166    
Common stock/units repurchased (815,231)   (328) (346) (24) (44) (812,734)   (813,476)   (1,755)
Amortization of restricted stock grants/compensation awards 1,200     2     198   200   1,000
Net income (loss) (897,808)             (885,648) (885,648) (208) (11,952)
Distributions declared on common stock (441,456)             (441,456) (441,456)    
Contributions from non-controlling interests 71,064                 11,171 59,893
Distributions to non-controlling interests (16,213)                 (9,299) (6,914)
Allocation to redeemable non-controlling interests (302) $ 300         (302)   (302)    
Ending Balance at Jun. 30, 2020 14,569,513   6,322 8,200 440 1,032 16,952,056 (2,749,989) 14,218,061 159,459 191,993
Beginning Balance at Mar. 31, 2020 13,815,602   6,111 7,830 439 964 16,278,758 (2,830,046) 13,464,056 161,305 190,241
Common stock issued 876,568   258 474 12 73 875,751   876,568    
Offering costs (28,581)           (28,581)   (28,581)    
Distribution reinvestment 123,244   54 51 3 8 123,128   123,244    
Common stock/units repurchased (299,009)   (101) (156) (14) (13) (297,305)   (297,589)   (1,420)
Amortization of restricted stock grants/compensation awards 600     1     99   100   500
Net income (loss) 318,642             314,439 314,439 (651) 4,854
Distributions declared on common stock (234,382)             (234,382) (234,382)    
Contributions from non-controlling interests 3,173                 1,916 1,257
Distributions to non-controlling interests (6,550)                 (3,111) (3,439)
Allocation to redeemable non-controlling interests 206 $ (200)         206   206    
Ending Balance at Jun. 30, 2020 $ 14,569,513   $ 6,322 $ 8,200 $ 440 $ 1,032 $ 16,952,056 $ (2,749,989) $ 14,218,061 $ 159,459 $ 191,993